K-Pharma specializes in early-stage neuroregenerative medicine and iPS drug discovery, focusing on the research, development, and manufacturing of innovative pharmaceuticals and medical products. Their cutting-edge approach aims to revolutionize treatment options and improve patient outcomes in the field of regenerative medicine.